journal cover

The Lymphatic System in Obesity, Insulin Resistance, and Cardiovascular Diseases

Frontiers in Physiology

Dec 5, 2019

Xinguo JiangStanley G Rockson

Abstract

Obesity, insulin resistance, dyslipidemia, and hypertension are fundamental clinical manifestations of the metabolic syndrome. Studies over the last few decades have implicated chronic inflammation and microvascular remodeling in the development of obesity and insulin resistance. Newer ...read more

Mentioned in this Paper

Diabetes Mellitus, Non-Insulin-Dependent
Study
Chronic Inflammation
Myocardial Infarction
Insulin Resistance
Dyslipidemias
Cardiovascular Diseases
Obesity
Atherosclerosis
Hypertensive Disease
3
1
4
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Similar Papers Found In These Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Type 2 Diabetes

This feed focuses on Type 2 Diabetes, a disease where the body doesn’t produce or respond to insulin anymore, leading to abnormal glucose levels in the blood.

Metabolic Syndrome

Metabolic syndrome is characterized by obesity, insulin resistance, dyslipidemia and hypertension. It significantly increases the risk for cardiovascular and disease and type 2 diabetes. Increasing prevalence has been associated with the increasing rates of obesity worldwide. Here is the latest research on the metabolic syndrome.

Obesity & CV Disease

Obesity is becoming a major health concern and epidemic worldwide. It is regarded as a systemic, low-grade inflammatory state and has been linked to several diseases, one of major importance is cardiovascular diseases. Here is the latest research on obesity and cardiovascular diseases.

© 2020 Meta ULC. All rights reserved

The Lymphatic System in Obesity, Insulin Resistance, and Cardiovascular Diseases

Frontiers in Physiology

Dec 5, 2019

Xinguo JiangStanley G Rockson

PMID: 31798464

DOI: 10.3389/fphys.2019.01402

Abstract

Obesity, insulin resistance, dyslipidemia, and hypertension are fundamental clinical manifestations of the metabolic syndrome. Studies over the last few decades have implicated chronic inflammation and microvascular remodeling in the development of obesity and insulin resistance. Newer ...read more

Mentioned in this Paper

Diabetes Mellitus, Non-Insulin-Dependent
Study
Chronic Inflammation
Myocardial Infarction
Insulin Resistance
Dyslipidemias
Cardiovascular Diseases
Obesity
Atherosclerosis
Hypertensive Disease
3
1
4

Related Papers

Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.
/papers/the-lymphatic-system-in-obesity-insulin/31798464